Search Results 61-70 of 16121 for pharmacogenetics
About this study · The impact that a clinical pharmacist and pharmacogenomic testing has on symptom management; · Patient perceptions, satisfaction and behaviors ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
THe purpose of this study is to examine the current and (potential) future therapeutic relevance of pharmacogenomics (PGx) testing for a cohort of cancer ...
The American Heart Association gives guidance on CYP2C19 genetic-guided testing for prescribing blood thinner drugs. A Mayo Clinic cardiologist chaired the ...
Consider pharmacogenetic testing. These tests check for specific genes ... Currently, pharmacogenetics tests are not a sure way to show if a medication ...
Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease Rochester, MN. This study will use a 22 gene pharmacogenomics panel on 30 ...
New pharmacogenetics program offers local hospital differentiation. Karl E. Bushman, M.D., knows that pharmacogenomics can make a difference. Through Mayo ...
... pharmacogenetics component of this study. Refusal to give consent for this component does not exclude a participant from participation in this clinical ...
This study recently used pharmacogenetic (PGx) data on 11,000 subjects within the Mayo Clinic Biobank as part of the Right Drug, Right Dose, Right Time ...
Challenges in Determining Genotypes for Pharmacogenetics in Allogeneic Hematopoietic Cell Transplant Recipients. ... Pharmacogenetic workup of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.